BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Diabetes mellitus
,
Hypothalamus
,
Personalized medicine
,
Valproic acid
,
rs4950928
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TNFR II
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Drug target sets for approved compounds
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Bivalent structure of a TNFR2-selective and agonistic TNF-α mutein Fc-fusion protein enhances the ex…
Anti-TNFR2 enhanced the antitumor activity of a new HMGN1/3M-052 stimulated dendritic cell vaccine i…
TNFR2 Signaling Regulates the Immunomodulatory Function of Oligodendrocyte Precursor Cells.
Tissue-restricted control of established central nervous system autoimmunity by TNF receptor 2-expre…
Differential role of TNFR1 and TNFR2 in the development of imiquimod-induced mouse psoriasis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of TNFR:Fc (Enbrel) in the Treatment of Asthma
Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (T…
A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-al…
A Randomized Phase II Study on the Optimization of Immunotherapy in Squamous Carcinoma of the Head a…
A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ